Tests of COVID-19 treatments in Korea gain speed – Global New Drug Development Company |

About us
Our Science
- EC-18 Technology Platform
- Potential Therapeutic Indications
  - CRIOM
  - CIN
  - ARS
  - COVID-19
  - ICI Combination
  - NASH
Pipeline
News
Partner & Collaboration
Contact

About us
Our Science
- EC-18 Technology Platform
- Potential Therapeutic Indications
  - CRIOM
  - CIN
  - ARS
  - COVID-19
  - ICI Combination
  - NASH
Pipeline
News
Partner & Collaboration
Contact

About us
Our Science
- EC-18 Technology Platform
- Potential Therapeutic Indications
  - CRIOM
  - CIN
  - ARS
  - COVID-19
  - ICI Combination
  - NASH
Pipeline
News
Partner & Collaboration
Contact

News

Enzychem in the News

Tests of COVID-19 treatments in Korea gain speed

Press Release
Enzychem in the News
Publications

United States Office

440 Sylvan Ave, STE 290B, Englewood Cliffs,
NJ U.S.A. 07632

Corporate Headquarters

10F, aT Center, 27 Gangnamdae-ro Seocho-gu,
Seoul, South Korea

R&D Center

13F, Gyeonggi Bio Center, 147,Gwanggyo-ro, Yeongtong-gu, Suwon-si,
Gyeonggi-do, South Korea

FOr More Information

info@enzychem.com

+1 201-591-1008

Privacy Policy
Terms & Conditions
Site map

CopyRight 2021 Enzychem Lifesciences Corporation, All Right Reserved.